Quick Answer
Moderna, Inc. reported Stockholders Equity of $8.65 billion for fiscal year 2025.
Moderna, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $8.65B | -20.6% |
| 2024 | $10.90B | -21.3% |
| 2023 | $13.85B | -27.6% |
| 2022 | $19.12B | +35.2% |
| 2021 | $14.14B | +452.3% |
| 2020 | $2.56B | +118.0% |
| 2019 | $1.18B | -23.2% |
| 2018 | $1.53B | +377.5% |
| 2017 | -$551.37M | -64.7% |
| 2016 | -$334.81M | -123.6% |
| 2015 | -$149.76M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.33B | -21.8% | -0.7% |
| June 30, 2025 | $9.40B | -19.7% | -6.6% |
| March 31, 2025 | $10.07B | -21.5% | -7.7% |
| December 31, 2024 | $10.90B | -21.3% | -8.6% |
| September 30, 2024 | $11.93B | -11.4% | +1.8% |
| June 30, 2024 | $11.71B | -30.9% | -8.6% |
| March 31, 2024 | $12.82B | -32.1% | -7.5% |
| December 31, 2023 | $13.85B | -27.6% | +3.0% |
- Moderna, Inc. showed a decrease of -20.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2015–2025 period, Moderna, Inc.’s stockholders equity has grown by 5875.9% (from -$149.76 million to $8.65 billion).
- The most recent figure is from Moderna, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: